An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Status:
Completed
Trial end date:
2018-12-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose-response of different doses of CHF 781 pMDI
on lung function and other clinical outcomes, to identify the optimal dose(s) in terms of
benefit/ risk ratio for further development in the target patient population.